Roles of inflammatory cytokines in the progression of gastric cancer: Friends or foes?

Gastric Cancer

Volumn 13, Issue 4, 2010, Pages 212-221

  Tsujimoto, Hironori ^a   Ono, Satoshi ^a   Ichikura, Takashi ^a   Matsumoto, Yusuke ^a   Yamamoto, Junji ^a   Hase, Kazuo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Cytokine; Tumor immunity; Tumor progression

Indexed keywords

CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; DNA; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; PROSTAGLANDIN E2; RANTES; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL ACTIVATION; CELL CYCLE ARREST; CELL PROLIFERATION; CYTOKINE PRODUCTION; DNA DAMAGE; DNA REPAIR; EMBASE; ENZYME ACTIVATION; HUMAN; INHIBITION KINETICS; MALIGNANT TRANSFORMATION; MEDLINE; METASTASIS POTENTIAL; NATURAL KILLER CELL; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STOMACH CANCER; SYSTEMATIC REVIEW; TUMOR IMMUNITY; UPREGULATION;

CYTOKINES; DISEASE PROGRESSION; HUMANS; INFLAMMATION MEDIATORS; STOMACH NEOPLASMS;

EID: 78650548230     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-010-0568-x     Document Type: Article

References (89)

1. D.M. Parkin 2004 International variation Oncogene 23 6329 6340 10.1038/sj.onc.1207726 15322508 1:CAS:528:DC%2BD2cXmvVOrtLY%3D
2. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
3. J.B. Crusius F. Canzian G. Capella A.S. Pena G. Pera N. Sala, et al. 2008 Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European Prospective Investigation Into Cancer and Nutrition (EPIC-EURGAST) Ann Oncol 19 1894 1902 10.1093/annonc/mdn400 18628242 1:STN:280: DC%2BD1cnosVKisg%3D%3D
4. C.A. Gonzalez N. Sala G. Capella 2002 Genetic susceptibility and gastric cancer risk Int J Cancer 100 249 260 10.1002/ijc.10466 12115538 1:CAS:528:DC%2BD38Xlt1Shsb4%3D
5. N. Hamajima M. Naito T. Kondo Y. Goto 2006 Genetic factors involved in the development of Helicobacter pylori-related gastric cancer Cancer Sci 97 1129 1138 10.1111/j.1349-7006.2006.00290.x 16879717 1:CAS:528:DC%2BD28XhtFemtbjI
6. L. Hou E.M. El-Omar J. Chen P. Grillo C.S. Rabkin A. Baccarelli, et al. 2007 Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer Carcinogenesis 28 118 123 10.1093/carcin/bgl130 16885196 1:CAS:528:DC%2BD28XhtlChtbjP
7. T. Starzynska K. Ferenc T. Wex T. Kahne J. Lubinski M. Lawniczak, et al. 2006 The association between the interleukin-1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population Am J Gastroenterol 101 248 254 10.1111/j.1572-0241.2006.00422.x 16454826 1:CAS:528:DC%2BD28XitFSgsbc%3D
8. W.E. Paul 1989 Pleiotropy and redundancy: T cell-derived lymphokines in the immune response Cell 57 521 524 10.1016/0092-8674(89)90121-9 2497989 1:CAS:528:DyaL1MXkt1Wktr0%3D
9. L.M. Coussens Z. Werb 2002 Inflammation and cancer Nature 420 860 867 10.1038/nature01322 12490959 1:CAS:528:DC%2BD38XpsFygtb4%3D
10. F. Balkwill A. Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 539 545 10.1016/S0140-6736(00)04046-0 11229684 1:CAS:528: DC%2BD3MXhsVKltb0%3D
11. M.J. Smyth E. Cretney M.H. Kershaw Y. Hayakawa 2004 Cytokines in cancer immunity and immunotherapy Immunol Rev 202 275 293 10.1111/j.0105-2896.2004. 00199.x 15546400 1:CAS:528:DC%2BD2MXhs1Ogsg%3D%3D
12. A. Ben-Baruch 2006 Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators Semin Cancer Biol 16 38 52 10.1016/j.semcancer.2005.07.006 16139507 1:CAS:528: DC%2BD28XotVCmug%3D%3D
13. W.W. Lin M. Karin 2007 A cytokine-mediated link between innate immunity, inflammation, and cancer J Clin Invest 117 1175 1183 10.1172/JCI31537 17476347 1:CAS:528:DC%2BD2sXlt1Omtrk%3D
14. R. Kim M. Emi K. Tanabe K. Arihiro 2006 Tumor-driven evolution of immunosuppressive networks during malignant progression Cancer Res 66 5527 5536 10.1158/0008-5472.CAN-05-4128 16740684 1:CAS:528:DC%2BD28XltFyjsbY%3D
15. C.F. Sun Y.Y. Hsieh K.W. Ngan W.T. Wang 2001 Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood Ann Clin Lab Sci 31 171 178 11337907 1:CAS:528:DC%2BD3MXjsFGmt74%3D
16. G. Chen F.J. Zhang M. Gong M. Yan 2007 Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients J Zhejiang Univ Sci B 8 560 565 10.1631/jzus.2007.B0560 17657857 1:CAS:528:DC%2BD2sXhtVajs77K
17. H. Tsujimoto T. Ichikura S. Ono H. Sugasawa S. Hiraki N. Sakamoto, et al. 2009 Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer Ann Surg Oncol 16 311 318 10.1245/s10434-008-0249-8 19037699
18. M. Ozaki S. Todo 2007 Surgical stress and tumor behavior: impact of ischemia-reperfusion and hepatic resection on tumor progression Liver Transpl 13 1623 1626 10.1002/lt.21230 18044752
19. K. Man K.T. Ng C.M. Lo J.W. Ho B.S. Sun C.K. Sun, et al. 2007 Ischemiareperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways Liver Transpl 13 1669 1677 10.1002/lt.21193 18044786
20. W.L. Deville F. Buntinx L.M. Bouter V.M. Montori H.C. de Vet D.A. van der Windt, et al. 2002 Conducting systematic reviews of diagnostic studies: didactic guidelines BMC Med Res Methodol 2 9 10.1186/1471-2288-2-9 12097142
21. F. Gianfagna E. De Feo C.M. van Duijn G. Ricciardi S. Boccia 2008 A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk Curr Genomics 9 361 374 10.2174/138920208785699544 19506726 1:CAS:528:DC%2BD1cXhtVSrs73M
22. F. Gorouhi F. Islami H. Bahrami F. Kamangar 2008 Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis Br J Cancer 98 1443 1451 10.1038/sj.bjc.6604277 18319718 1:CAS:528:DC%2BD1cXks12gtbc%3D
23. F. Balkwill 2009 Tumour necrosis factor and cancer Nat Rev Cancer 9 361 371 10.1038/nrc2628 19343034 1:CAS:528:DC%2BD1MXjvF2gtLk%3D
24. S. Mocellin C.R. Rossi P. Pilati D. Nitti 2005 Tumor necrosis factor, cancer and anticancer therapy Cytokine Growth Factor Rev 16 35 53 10.1016/j.cytogfr.2004.11.001 15733831 1:CAS:528:DC%2BD2MXhslChsr0%3D
25. M. Jaiswal N.F. LaRusso L.J. Burgart G.J. Gores 2000 Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 184 190 10646872 1:CAS:528:DC%2BD3cXnt1antQ%3D%3D
26. S.J. Leibovich P.J. Polverini H.M. Shepard D.M. Wiseman V. Shively N. Nuseir 1987 Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha Nature 329 630 632 10.1038/329630a0 2443857 1:STN:280: DyaL1c%2FhsVagsQ%3D%3D
27. Y. Mochizuki H. Nakanishi Y. Kodera S. Ito Y. Yamamura T. Kato, et al. 2004 TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line Clin Exp Metastasis 21 39 47 10.1023/B:CLIN.0000017181.01474.35 15065601 1:CAS:528:DC%2BD2cXhsV2qu7o%3D
28. S. Kabir G.A. Daar 1995 Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma Cancer Lett 95 207 212 10.1016/0304-3835(95)03895-4 7656232 1:CAS:528:DyaK2MXnsFWgsL8%3D
29. C.W. Wu C.W. Chi M.C. Hsieh M.F. Chao W.Y. Lui F.K. P'Eng 1998 Serum tumor necrosis factor in patients with gastric cancer Anticancer Res 18 1597 1599 9673376 1:STN:280:DyaK1czjvVSqsQ%3D%3D
30. N.M. Forones S.V. Mandowsky L.G. Lourenco 2001 Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer Hepatogastroenterology 48 1199 1201 11490833 1:STN:280: DC%2BD3MvksFOnsg%3D%3D
31. J. Ma H. Sawai Y. Matsuo N. Ochi A. Yasuda H. Takahashi, et al. 2008 Interleukin-1alpha enhances angiogenesis and is associated with liver metastatic potential in human gastric cancer cell lines J Surg Res 148 197 204 10.1016/j.jss.2007.08.014 18395750 1:CAS:528:DC%2BD1cXosVyitbs%3D
32. Y. Furuya T. Ichikura H. Mochizuki N. Shinomiya 2000 Relationship between interleukin-1-alpha concentration in tumors and cell growth in gastric cancer, determined using flow cytometry Gastric Cancer 3 86 90 10.1007/PL00011701 11984716
33. K. Uefuji T. Ichikura H. Mochizuki 2005 Increased expression of interleukin-1alpha and cyclooxygenase-2 in human gastric cancer: a possible role in tumor progression Anticancer Res 25 3225 3230 16101131 1:CAS:528: DC%2BD2MXps1Kgtr0%3D
34. S. Tomimatsu T. Ichikura H. Mochizuki 2001 Significant correlation between expression of interleukin-1alpha and liver metastasis in gastric carcinoma Cancer 91 1272 1276 10.1002/1097-0142(20010401)91:7<1272::AID- CNCR1128>3.0.CO;2-Z 11283926 1:CAS:528:DC%2BD3MXislyhtb4%3D
35. Y. Furuya T. Ichikura H. Mochizuki 1999 Interleukin-1alpha concentration in tumors as a risk factor for liver metastasis in gastric cancer Surg Today 29 288 289 10.1007/BF02483025 10192746 1:STN:280:DyaK1M3gs12ltg%3D%3D
36. I.L. Beales 2002 Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture BMC Gastroenterol 2 7 15 10.1186/1471-230X-2-7 11936957
37. E.M. El-Omar M. Carrington W.H. Chow K.E. McColl J.H. Bream H.A. Young, et al. 2000 Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398 402 10.1038/35006081 10746728 1:CAS:528: DC%2BD3cXitlyltb4%3D
38. F. Kamangar C. Cheng C.C. Abnet C.S. Rabkin 2006 Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis Cancer Epidemiol Biomarkers Prev 15 1920 1928 10.1158/1055-9965.EPI-06-0267 17035400 1:CAS:528:DC%2BD28XhtVGktbnI
39. D.A. Deans S.J. Wigmore H. Gilmour S. Paterson-Brown J.A. Ross K.C. Fearon 2006 Elevated tumour interleukin-1beta is associated with systemic inflammation: a marker of reduced survival in gastrooesophageal cancer Br J Cancer 95 1568 1575 10.1038/sj.bjc.6603446 17088911 1:CAS:528:DC%2BD28Xht1CntrzL
40. R. Ito W. Yasui H. Kuniyasu H. Yokozaki E. Tahara 1997 Expression of interleukin-6 and its effect on the cell growth of gastric carcinoma cell lines Jpn J Cancer Res 88 953 958 9414656 1:CAS:528:DyaK2sXnt1Gjsr0%3D
41. C.M. Leu F.H. Wong C. Chang S.F. Huang C.P. Hu 2003 Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways Oncogene 22 7809 7818 10.1038/sj.onc.1207084 14586407 1:CAS:528:DC%2BD3sXosVykurg%3D
42. T. Ashizawa R. Okada Y. Suzuki M. Takagi T. Yamazaki T. Sumi, et al. 2005 Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor Gastric Cancer 8 124 131 10.1007/s10120-005-0315-x 15864720 1:CAS:528:DC%2BD2MXjvVCntbc%3D
43. M. Ikeguchi T. Hatada M. Yamamoto T. Miyake T. Matsunaga Y. Fukumoto, et al. 2009 Serum interleukin-6 and -10 levels in patients with gastric cancer Gastric Cancer 12 95 100 10.1007/s10120-009-0509-8 19562463 1:CAS:528: DC%2BD1MXnvVWqsrg%3D
44. H. Sugai K. Kono A. Takahashi F. Ichihara H. Kawaida H. Fujii, et al. 2004 Characteristic alteration of monocytes with increased intracellular IL-10 and IL-12 in patients with advanced-stage gastric cancer J Surg Res 116 277 287 10.1016/j.jss.2003.10.008 15013367 1:CAS:528:DC%2BD2cXptFSlsA%3D%3D
45. T. Morisaki M. Katano A. Ikubo K. Anan M. Nakamura K. Nakamura, et al. 1996 Immunosuppressive cytokines (IL-10, TGF-beta) genes expression in human gastric carcinoma tissues J Surg Oncol 63 234 239 10.1002/(SICI)1096- 9098(199612)63:4<234::AID-JSO4>3.0.CO;2-D 8982367 1:STN:280: DyaK2s7js12qsg%3D%3D
46. T. Sakamoto H. Saito S. Tatebe S. Tsujitani M. Ozaki H. Ito, et al. 2006 Interleukin-10 expression significantly correlates with minor CD8+ T-cell infiltration and high microvessel density in patients with gastric cancer Int J Cancer 118 1909 1914 10.1002/ijc.21598 16287061 1:CAS:528:DC%2BD28Xjt1Gqtb0%3D
47. F. De Vita M. Orditura G. Galizia C. Romano S. Infusino A. Auriemma, et al. 1999 Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies Cancer 86 1936 1943 10.1002/(SICI)1097-0142(19991115)86:10<1936: :AID-CNCR9>3.0.CO;2-9 10570416
48. T. Majima T. Ichikura S. Seki E. Takayama H. Hiraide H. Mochizuki 2001 Interleukin-10 and interferon-gamma levels within the peritoneal cavity of patients with gastric cancer J Surg Oncol 78 124 130 10.1002/jso.1131 11579390 1:CAS:528:DC%2BD3MXnslKhur4%3D
49. A. Szaflarska A. Szczepanik M. Siedlar A. Czupryna M. Sierzega T. Popiela, et al. 2009 Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer Anticancer Res 29 5005 5012 20044609 1:CAS:528: DC%2BC3cXht1Gqur0%3D
50. T. Majima T. Ichikura S. Seki E. Takayama A. Matsumoto T. Kawabata, et al. 2002 The influence of interleukin-10 and interleukin-18 on interferon-gamma production by peritoneal exudate cells in patients with gastric carcinoma Anticancer Res 22 1193 1199 12168924 1:CAS:528:DC%2BD38XmsFWrtrw%3D
51. C. Fortis M. Foppoli L. Gianotti L. Galli G. Citterio G. Consogno, et al. 1996 Increased interleukin-10 serum levels in patients with solid tumours Cancer Lett 104 1 5 10.1016/0304-3835(96)04213-9 8640735 1:CAS:528: DyaK28Xjt1Sgtrw%3D
52. H. Hatanaka Y. Abe M. Naruke T. Tokunaga Y. Oshika T. Kawakami, et al. 2001 Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in nonsmall cell lung cancer Clin Cancer Res 7 1287 1292 11350896 1:CAS:528:DC%2BD3MXktlelsro%3D
53. M.K. Gately L.M. Renzetti J. Magram A.S. Stern L. Adorini U. Gubler, et al. 1998 The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses Annu Rev Immunol 16 495 521 10.1146/annurev.immunol. 16.1.495 9597139 1:CAS:528:DyaK1cXisl2gsbs%3D
54. M. Shibata T. Nezu H. Kanou H. Abe M. Takekawa M. Fukuzawa 2002 Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer J Clin Gastroenterol 34 416 420 10.1097/00004836-200204000-00006 11907352 1:CAS:528:DC%2BD38XjtFSkt7o%3D
55. S. Murakami K. Okubo Y. Tsuji H. Sakata S. Hamada R. Hirayama 2004 Serum interleukin-12 levels in patients with gastric cancer Surg Today 34 1014 1019 10.1007/s00595-004-2860-z 15580384 1:CAS:528:DC%2BD2cXhtVCmur3M
56. K. Nakamura H. Okamura M. Wada K. Nagata T. Tamura 1989 Endotoxin-induced serum factor that stimulates gamma interferon production Infect Immun 57 590 595 2492265 1:CAS:528:DyaL1MXhtFartb0%3D
57. S. Park S. Cheon D. Cho 2007 The dual effects of interleukin-18 in tumor progression Cell Mol Immunol 4 329 335 17976312 1:CAS:528:DC%2BD2sXhsVeks7vJ
58. T. Majima T. Ichikura K. Chochi T. Kawabata H. Tsujimoto H. Sugasawa, et al. 2006 Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity Int J Cancer 118 388 395 10.1002/ijc.21334 16049975 1:CAS:528:DC%2BD2MXhtlWqsL7K
59. T. Kawabata T. Ichikura T. Majima S. Seki K. Chochi E. Takayama, et al. 2001 Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma Cancer 92 2050 2055 10.1002/1097-0142(20011015)92:8<2050::AID-CNCR1544>3.0.CO;2-5 11596019 1:STN:280:DC%2BD3MrkvVKnsg%3D%3D
60. Z.B. Ye T. Ma H. Li X.L. Jin H.M. Xu 2007 Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma World J Gastroenterol 13 1747 1751 10.3748/wjg.13.6264 17461482 1:CAS:528: DC%2BD2sXlvFCmtL8%3D
61. W. Chen S.M. Wahl 2003 TGF-beta: the missing link in CD4 + CD25 + regulatory T cell-mediated immunosuppression Cytokine Growth Factor Rev 14 85 89 10.1016/S1359-6101(03)00003-0 12651220 1:CAS:528:DC%2BD3sXitVymtLo%3D
62. H. Kawaida K. Kono A. Takahashi H. Sugai K. Mimura N. Miyagawa, et al. 2005 Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer J Surg Res 124 151 157 10.1016/j.jss.2004.10.004 15734494 1:CAS:528:DC%2BD2MXhslWrsbc%3D
63. H. Saito T. Osaki D. Murakami T. Sakamoto S. Kanaji S. Ohro, et al. 2007 Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters J Surg Oncol 95 123 128 10.1002/jso.20612 17262742 1:CAS:528:DC%2BD2sXisFyksrY%3D
64. K. Yanagihara M. Tsumuraya 1992 Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells Cancer Res 52 4042 4045 1319836 1:CAS:528:DyaK38XlsVChsb8%3D
65. H. Fu Z. Hu J. Wen K. Wang Y. Liu 2009 TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways Acta Biochim Biophys Sin (Shanghai) 41 648 656 10.1093/abbs/gmp053 1:CAS:528:DC%2BD1MXpvF2hs70%3D
66. T. Inoue Y.S. Chung M. Yashiro S. Nishimura T. Hasuma S. Otani, et al. 1997 Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells Jpn J Cancer Res 88 152 159 9119743 1:CAS:528:DyaK2sXhs1KksrY%3D
67. A. Komuro M. Yashiro C. Iwata Y. Morishita E. Johansson Y. Matsumoto, et al. 2009 Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling J Natl Cancer Inst 101 592 604 10.1093/jnci/djp058 19351925 1:CAS:528:DC%2BD1MXkvFKju7c%3D
68. Y. Maehara Y. Kakeji A. Kabashima Y. Emi A. Watanabe K. Akazawa, et al. 1999 Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma J Clin Oncol 17 607 614 10080606 1:CAS:528:DyaK1MXht1Wmu7g%3D
69. K. Vagenas C. Spyropoulos V. Gavala A.C. Tsamandas 2007 TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostic factors and patient survival J Surg Res 139 182 188 10.1016/j.jss.2006.10.005 17270215 1:CAS:528:DC%2BD2sXktF2kur8%3D
70. H. Saito S. Tsujitani S. Oka A. Kondo M. Ikeguchi M. Maeta, et al. 1999 The expression of transforming growth factor-beta1 is signifi- cantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma Cancer 86 1455 1462 10.1002/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0.CO;2-L 10526273 1:CAS:528:DyaK1MXntlSkur0%3D
71. K. Kono H. Kawaida A. Takahashi H. Sugai K. Mimura N. Miyagawa, et al. 2006 CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers Cancer Immunol Immunother 55 1064 1071 10.1007/s00262-005-0092-8 16328385 1:CAS:528:DC%2BD28XkvFOjurY%3D
72. A.M. Wolf D. Wolf M. Steurer G. Gastl E. Gunsilius B. Grubeck-Loebenstein 2003 Increase of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 9 606 612 12576425
73. F. Ichihara K. Kono A. Takahashi H. Kawaida H. Sugai H. Fujii 2003 Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clin Cancer Res 9 4404 4408 14555512
74. T. Sasada M. Kimura Y. Yoshida M. Kanai A. Takabayashi 2003 CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer 98 1089 1099 10.1002/cncr.11618 12942579
75. T. Kakinuma S.T. Hwang 2006 Chemokines, chemokine receptors, and cancer metastasis J Leukoc Biol 79 639 651 10.1189/jlb.1105633 16478915 1:CAS:528:DC%2BD28XjsFCmur4%3D
76. A. Zlotnik 2006 Chemokines and cancer Int J Cancer 119 2026 2029 10.1002/ijc.22024 16671092 1:CAS:528:DC%2BD28XhtVSks7bE
77. Y. Kitadai K. Haruma N. Mukaida Y. Ohmoto N. Matsutani W. Yasui, et al. 2000 Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8 Clin Cancer Res 6 2735 2740 10914718 1:CAS:528: DC%2BD3cXlslent7c%3D
78. H. Konno M. Ohta M. Baba S. Suzuki S. Nakamura 2003 The role of circulating IL-8 and VEGF protein in the progression of gastric cancer Cancer Sci 94 735 740 10.1111/j.1349-7006.2003.tb01511.x 12901801 1:CAS:528: DC%2BD3sXotFSlt7o%3D
79. Y. Kitadai K. Haruma K. Sumii S. Yamamoto T. Ue H. Yokozaki, et al. 1998 Expression of interleukin-8 correlates with vascularity in human gastric carcinomas Am J Pathol 152 93 100 9422527 1:CAS:528:DyaK1cXktlynsw%3D%3D
80. Y. Kitadai Y. Takahashi K. Haruma K. Naka K. Sumii H. Yokozaki, et al. 1999 Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice Br J Cancer 81 647 653 10.1038/sj.bjc.6690742 10574250 1:CAS:528:DyaK1MXntVSqurw%3D
81. H. Sugasawa T. Ichikura M. Kinoshita S. Ono T. Majima H. Tsujimoto, et al. 2008 Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination Int J Cancer 122 2535 2541 10.1002/ijc.23401 18246596 1:CAS:528:DC%2BD1cXltlaiu78%3D
82. H. Sugasawa T. Ichikura H. Tsujimoto M. Kinoshita D. Morita S. Ono, et al. 2008 Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer J Surg Oncol 97 445 450 10.1002/jso.20984 18297689
83. J.M. Wang X. Deng W. Gong S. Su 1998 Chemokines and their role in tumor growth and metastasis J Immunol Methods 220 1 17 10.1016/S0022-1759(98)00128-8 9839921 1:CAS:528:DyaK1cXntVygsL0%3D
84. M.L. Sanz M.L. Subira A. Oehling J.L. Hernandez G. Zornoza 1982 Immunologic study of carcinoma of the digestive tract. Effects of the tumor stage. I. Cellular immunity in the preoperative period Allergol Immunopathol (Madr) 10 33 42 1:STN:280:DyaL383gtlSitQ%3D%3D
85. T.J. Jang 2009 The number of Foxp3-positive regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer Pathol Res Pract 206 34 38 10.1016/j.prp.2009.07.019 19819643
86. A. Takagi S. Kamiya Y. Koga U. Ohta H. Kobayashi T. Shirai, et al. 1997 Analysis of interleukin-8 secretion induced by Helicobacter pylori from the gastric epithelial cell line MKN45: a mechanism independent of the intensity of cytotoxicity J Gastroenterol Hepatol 12 368 372 10.1111/j.1440-1746.1997. tb00444.x 9195382 1:CAS:528:DyaK2sXkslersr0%3D
87. W. Zou 2005 Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 263 274 10.1038/nrc1586 15776005 1:CAS:528:DC%2BD2MXivVars7g%3D
88. J.W. Hadden 2003 Immunodeficiency and cancer: prospects for correction Int Immunopharmacol 3 1061 1071 10.1016/S1567-5769(03)00060-2 12860163 1:CAS:528:DC%2BD3sXlt1altbo%3D
89. M. Scartozzi A. Bittoni M. Pistelli E. Galizia R. Berardi R. Giampieri, et al. 2009 Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives Cancer Treat Rev 35 451 462 10.1016/j.ctrv.2009.04.008 19467788 1:CAS:528:DC%2BD1MXptlSks7w%3D